During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.
Benzinga readers can review the latest analyst takes on their favorite stocks by visiting our Analyst Stock Ratings page. Traders can sort through Benzinga's extensive database of analyst ratings, including by analyst accuracy.
Below are the ratings of the most accurate analysts for three high-yielding stocks in the materials sector.
Dow Inc. DOW
- Dividend Yield: 5.13%
- Mizuho analyst John Roberts maintained a Buy rating and cut the price target from $62 to $60 on July 26. This analyst has an accuracy rate of 71%.
- Wells Fargo analyst Michael Sison maintained an Overweight rating and cut the price target from $65 to $62 on July 26. This analyst has an accuracy rate of 69%.
- Recent News: On July 25, the company said sales declined 4% Y/Y to $10.9 billion, missing the consensus of $11.01 billion.
The Chemours Company CC
- Dividend Yield: 4.11%
- UBS analyst Joshua Spectorupgraded the stock from Neutral to Buy and boosted the price target from $28 to $30 on July 9. This analyst has an accuracy rate of 63%.
- Mizuho analyst John Roberts initiated coverage on the stock with a Neutral rating and a price target of $25 on June 7. This analyst has an accuracy rate of 71%.
- Recent News: On July 24, Chemours Company declared a quarterly cash dividend of 25 cents per share.
International Paper Company IP
- Dividend Yield: 3.98%
- Wells Fargo analyst Gabe Hajde maintained an Equal-Weight and raised the price target from $43 to $45 on July 25. This analyst has an accuracy rate of 80%.
- RBC Capital analyst Matthew McKellar maintained an Outperform rating and boosted the price target from $52 to $56 on July 25. This analyst has an accuracy rate of 63%.
- Recent News: On July 24, International Paper reported second-quarter FY24 sales growth of 1.1% year-on-year to $4.73 billion, missing the analyst consensus estimate of $4.78 billion.
Read More:
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.